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Abstract 
 
Hyaluronan plays a role in keratinocyte proliferation and differentiation.  In addition, hyaluronan 
has been shown to have different biological activities depending on its molecular weight.  It has 
been reported that hyaluronan-mediated CD44 activation regulates keratinocyte differentiation.  
Therefore, the aim of the present study was to investigate the influence of hyaluronan 
tetrasaccharides (HA4) on the regulation of keratinocyte differentiation, CD44 gene expression, and 
CD44-phosphorylated protein in human keratinocytes, and compare HA4 with high molecular 
weight hyaluronan (HA).  Normal human epidermal keratinocytes (NHEKs) were treated at doses 
of 1 µg/mL HA or HA4.  After treatment, cell viability was checked using an MTT assay.  Each 
differentiation marker and CD44 mRNA expression was detected by real-time PCR.  Each 
differentiation marker and CD44-phosphorylated protein was assessed by western blotting.  HA and 
HA4 showed no cytotoxicity up to a dose of 1 µg/mL.  On day 3 after HA4 treatment, each 
differentiation marker mRNA and K10 protein level was more than that of the control.  On day 9, 
late differentiation marker mRNA and protein levels were increased with HA and HA4 treatment.  
In addition, HA4 treatment increased the expression of CD44 mRNA, CD44-phosphorylated protein, 
and intracellular calcium concentrations.  HA4 enhanced keratinocyte differentiation and increased 
CD44-phosphorylated protein levels.  HA4 may induce epidermal differentiation through 
phosphorylation of CD44. 
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Introduction 
 
The major function of the epidermis is to provide a barrier between the external environment and the 
organism.  The main cell in the epidermis is the keratinocyte.  In the epidermis, dividing stem 
cells give rise to progeny cells destined to migrate upward through the epidermal layer until they die 
and are lost from the surface.  This process is called differentiation.  In the normal mammalian 
epidermis, cell division and expression of keratins K5/K14 in the basal layer are followed by 
K1/K10, the keratin bundling protein filaggrin, and cornified envelope proteins such as involucrin, 
loricrin, and transglutaminase (TGase) [1, 2].  Terminal differentiation of mammalian epidermal 
keratinocytes results in the formation of the stratum corneum, which consists of dead cells filled with 
cross-linked keratin protein surrounded by a toughened cornified cell envelope. 
     Hyaluronan, which is composed of repeated β-1,4-glucuronic acid-1,3-N-acetylglucosamine 
disaccharide units, is a non-sulfated glycosaminoglycan with a molecular weight of over 1,000 kDa. 
Hyaluronan is one of the major extracellular matrix components in the skin.  Hyaluronan exists 
freely in extracellular matrix spaces, but is also involved in many biological processes such as tissue 
homeostasis, cell proliferation, cell migration, cell differentiation, angiogenesis, tumor biology, and 
repair processes by the interface of each protein [3].   
CD44 is the major receptor of hyaluronan [4].  The interaction between CD44 and 
hyaluronan can mediate both cell-cell and cell-extracellular matrix interactions and has been shown 
to be important in a variety of physiological and pathophysiological processes, including tumour 
metastasis, wound healing, and leukocyte extravasation at sites of inflammation [5].  The ability of 
CD44 to bind hyaluronan is tightly regulated.  CD44 can exist in inactive non-binding forms or an 
active ligand binding form.   
Stimulation by hyaluronan of the living body appears to depend on many factors including 
hyaluronan chain length and hyaluronan receptors such as CD44.  For example, high molecular 
weight hyaluronan was demonstrated to induce anti-inflammatory and anti-angiogenic responses [6, 
7].  In contrast, low molecular weight hyaluronan has been implicated in several 
biological processes including angiogenesis, cell proliferation, maturation, migration, 
activation of protein tyrosine kinase cascades, and inflammatory gene expression [8-14]  
Hyaluronan oligosaccharides, which are much smaller than low molecular weight hyaluronan, 
up-regulates heat shock protein 72 expression [15].  It has been reported that hyaluronan-mediated 
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CD44 activation regulates keratinocyte differentiation [16].  In this way, hyaluronan was reported 
to have many functions, but little is known about the effect of low molecular hyaluronan on 
keratinocyte differentiation.  In this study, we aimed at investigating the influence of hyaluronan 
oligosaccharides (HA4) with two repeats of the disaccharide unit on the regulation of keratinocyte 
differentiation in human keratinocytes, and compared HA4 with high molecular weight hyaluronan.  
In addition, CD44 gene expression and CD44-phosphorylated protein amounts were measured and 
assessed. 
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Materials and methods 
 
Materials 
 
Abdominal skin origin normal human epidermal keratinocytes (NHEKs) were purchased from 
Biopredic (Rennes, France).  HuMedia-KG2 was purchased from Kurabo (Osaka, Japan).  
RNAiso Plus, the PrimeScript® RT reagent Kit, and SYBR® Premix Ex TaqTM were purchased from 
Takara Bio (Shiga, Japan).  Primers were purchased from Invitrogen (CA USA).  Polyvinylidene 
difluoride membranes and western blotting detection reagents were purchased from GE Healthcare 
(Buckinghamshire, UK).  HA4 (99.14%) (776.3 Da) were provided by Glycoscience Laboratories 
Inc. (Tokyo, Japan).  High-molecular weight hyaluronan (HA) (>1200 kDa) produced by a 
Streptococcus zooepidemicus was used.  All other chemicals and solvents used were analytical 
grade. 
 
 
Cell culture 
 
Cells were seeded in 100 mm dishes (2.0 × 105 cells per dish).  NHEKs were grown in 
HuMedia-KB2 supplemented with 10 µg/mL insulin, 0.1 ng/mL human epidermal growth factor, 0.5 
µg/mL hydrocortisone, 50 µg/mL gentamicin, 50 ng/mL amphotericin B, and 0.4% (v/v) bovine 
pituitary extract.  NHEKs were incubated in a humidified atmosphere of 5% CO2 at 37ºC.  The 
culture medium was changed every day.  Once cells had become subconfluent, they were 
subcultured in 60 mm dishes (1.5-2.0 × 105 cells per dish) in the same medium.  After culturing for 
1 day, cells were treated at doses of 1 µg/mL HA or HA4 and cultured. 
 
 
MTT assay 
 
NHEKs were seeded on 24-well culture plates and incubated for 1 day.  After treatment with HA 
and HA4 for 24 h, cells received 0.5 mg/mL MTT solution and were incubated for a further 3 h.  
The medium was removed and the resulting formazan crystal was solubilized in 1 mL of 0.04 M 
hydrochloric acid/isopropyl alcohol.  The optical density at 570 nm was determined using a 
microplate reader (SpectraMax M2e, Molecular Devices, Tokyo, Japan). 
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RNA extraction and quantitative real-time PCR 
 
Total RNA was isolated from cells following standard procedures using RNAiso Plus.  The first 
strand of cDNA was synthesized from 0.5 µg total RNA from cell samples using the PrimeScript® 
RT reagent Kit and a thermal cycler (Veriti, Applied Biosystems, CA, USA).  The cDNA samples 
generated were diluted and used for real-time PCR analysis.  Briefly, 2 µL of diluted cDNA was 
mixed with both forward and reverse primers (Table 1) and SYBR® Premix Ex TaqTM in 20 µL final 
volumes.  Amplification was performed using the Real-Time PCR System (ABI PRISM® 7500, 
Applied Biosystems, CA, USA).  Amplified PCR products were quantified by measuring each gene 
and GAPDH mRNA calculated cycle thresholds (CT).  The amount of specific mRNA in samples 
was calculated from the standard curve and was normalized with GAPDH mRNA.  Results were 
expressed as an n-fold difference relative to normal controls (relative expression levels). 
 
 
Western blotting assay 
 
NHEKs were washed twice in PBS and subsequently dissolved in lysis buffer solution (62.5 mM 
Tris-HCl, pH 6.8, 2% w/v SDS, 10% glycerol), 1 mM phenylmethylsulfonyl fluoride, and 1 mM 
sodium orthovanadate.  Proteins were heated in sample buffer (0.1 M Tris-HCl, pH 6.8, 25% 
glycerol, 5% SDS, 0.01% bromophenol blue, 5% 2-mercaptoethanol) for 4 min at 95ºC and 
subjected to SDS-PAGE.  Proteins were blotted onto polyvinylidene difluoride (PVDF) membranes 
using a tank apparatus (Bio-Rad, CA, USA).  Subsequently, blots were transferred to a blocking 
buffer (Tris-buffered saline (TBS), pH 7.6, 0.1% Tween 20, 5% w/v powdered-skim milk) and 
incubated for 1 h at room temperature.  After being washed in three stages in wash buffer (TBS, pH 
7.6, 0.1% Tween 20), blots were incubated with primary antibody in 5% powdered-skim milk at 
room temperature.  After 1 h of gentle shaking, blots were washed three times in wash buffer.  
Antibodies were detected with peroxidase-conjugated anti-rabbit IgG and peroxidase-positive bands 
were detected by LAS-1000 (Fujifilm, Tokyo, Japan). 
 
 
Data analysis 
 
Analysis was performed using Statistical Analysis SAS statistical software ver. 9.2 (SAS Institute, 
Cary, NC).  Indicated P-values were derived from the Tukey’s post-hoc multiple comparison test.   
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Results 
 
The cytotoxicity of HA and HA4 on NHEKs 
 
To investigate the cytotoxicity of HA and HA4 on cells, we treated NHEKs with HA and HA4.  
After treatment for 24 h, cell viability was checked by the MTT assay.  As a result, HA and HA4 
showed no cytotoxicity up to a dose of 1 µg/mL (Fig. 1).   
 
Fig. 1 
 
 
Differentiation marker mRNA expressions and protein evaluation 
 
The mRNA expression levels of differentiation marker mRNA were assessed by quantitative 
real-time PCR in NHEKs relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH).  
NHEKs were cultured with medium as controls and HA and HA4 (1 µg/mL) for 4, 8, 24, 72, and 216 
h.  After each hour of treatment, quantitative real-time PCR was used to determine the levels of K5, 
K10, involucrin, profilaggrin, and TGase mRNA relative to the control gene.  As a result, treatment 
of NHEKs with HA and HA4 increased K10, involucrin, profilaggrin and TGase mRNA expression 
in a time dependent manner.  HA and HA4 treatment for 4, 8, and 24 h enhanced little change in the 
expressions of all differentiation marker mRNA (data not shown).  The expressions of involucrin, 
profilaggrin, and TGase mRNA with HA4 treatment for 72 h (3 days) were 1.3-, 1.3-, and 1.5-fold 
higher than control (Fig. 2).  The expressions of all differentiation marker mRNA were increased 
with HA and HA4 treatment for 216 h (9 days).  Specifically, the expressions of involucrin, 
profilaggrin, and TGase mRNA of late differentiation markers were notably increased with HA and 
HA4 treatment.  The expressions of profilaggrin and TGase mRNA with HA treatment were 1.6- 
and 1.6-fold higher than control, increases which were considered to be significant.  In addition, the 
expressions of profilaggrin and TGase mRNA with HA4 treatment were increased 1.5- and 1.6-fold 
over that of control (Fig. 3), increases which were also considered to be significant. 
 
Fig. 2 
Fig. 3 
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     Next, the protein levels of K10, involucrin, and filaggrin were assessed by western blotting in 
NHEKs relative to β–actin.  NHEKs were cultured with medium as controls and HA and HA4 for 3 
and 9 days.  As a result, K10 protein levels with HA4 treatment for 3 days was 2.2-fold higher than 
control, but the cultured did not express involucrin and filaggrin proteins of late differentiation 
markers (Fig. 4).  Involucrin protein levels with HA and HA4 treatment for 9 days were 1.4- and 
2.0-fold higher, and filaggrin protein levels with HA and HA4 treatment were 1.4- and 1.2-fold 
higher than control (Fig. 5). 
 
Fig. 4 
Fig. 5 
 
 
CD44 mRNA expression and CD44-phosphorylated protein levels 
 
The expression of CD44 mRNA was investigated by real-time PCR.  NHEKs were cultured with 
medium as controls and HA and HA4 for 4, 8, 24, and 216 h.  As a result, HA4 treatment increased 
the expression of CD44 mRNA.  Specifically, CD44 mRNA expression with HA4 treatment was 
increased 1.5-fold over on 216 h (9 days) that of control (Fig. 6), an increase that was considered to 
be significant.  The CD44-phosphorylated protein was assessed by western blotting.  NHEKs were 
cultured with medium as controls and HA and HA4 for 8 and 24 h.  As a result, 
CD44-phosphorylated protein levels were significantly increased with HA4 than that of the control 
and HA after HA and HA4 treatment for 8 h (Fig. 7a).  HA and HA4 treatment for 24 h enhanced 
little change in CD44-phosphorylated protein levels (Fig. 7b). 
 
Fig. 6 
Fig. 7 
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Discussion 
 
Our group previously reported that HA4 permeated through skin by passive diffusion and treatment 
with HA4 improved skin functional recovery after UVA irradiation [17].  Next, to elucidate the 
healing mechanisms of HA4, we examined the effects of HA4 on epidermal differentiation in 
NHEKs.  Our studies have suggested that keratinocyte differentiation was enhanced by HA4. 
     Involucrin and filaggrin were late markers of differentiation that were specifically expressed in 
suprabasal (granular) epidermal layers [18].  Involucrin protein and mRNA levels were regulated 
by agents that regulate keratinocyte differentiation, calcium, hydrocortisone, retinoids, and vitamin 
D [19-21].  Hydrocortisone, which inhibits epidermal proliferation and enhances terminal 
differentiation, is accompanied by a decrease in epidermal hyaluronan [22].  In Streptomyces 
hyaluronidase-treated cultures, profilaggrin levels were increased relative to controls [23].  In 
addition, it has been shown using CD4 knockout mice that epidermal differentiation is stimulated by 
hyaluronan [16].  In this way, hyaluronan and keratinocyte differentiation were related closely.  In 
this study, it was revealed that HA4 enhanced keratinocyte differentiation in the same manner as HA 
(Fig. 2-5).  Moreover, the keratinocyte differentiation induction by HA4 was faster than HA (Fig. 2, 
4).  The expression of each differentiation marker mRNA with HA4 treatment for 3 days was 
increased than that of the control (Fig. 2).  In addition, K10 protein levels with HA4 treatment for 3 
days were significantly increased 2.2-fold higher than control (Fig. 4).  The expressions of late 
differentiation marker mRNA with HA4 and HA treatment for 9 days were significantly increased 
than that of the control (Fig. 3).  In addition, involucrin and filaggrin protein levels with HA4 and 
HA treatment for 9 days were increased 2.0- and 1.2-fold over that of the control (Fig. 5).  HA4 
permeated through skin by passive diffusion [17].  However, hyaluronan can’t penetrate into the 
skin membrane because of high water solubility and a high molecular weight (100 kDa).  
Consequently, HA4 may induce differentiation of the skin by only application. 
     Next, we examined the mechanism of keratinocyte differentiation.  CD44 was widely 
distributed, which makes it the major hyaluronan receptor on most cell types.  The major receptor 
for hyaluronan on the surface of epidermal keratinocytes was CD44.  Activation of CD44 by 
hyaluronan increased signal transduction and several downstream biological activities.  For 
example, hyaluronan and CD44 interaction induced intracellular signal cascades that regulate 
cell-cell adhesion, cell migration, and proliferation, which are required for morphogenesis and 
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wound healing [24-30].  In addition, the interaction between hyaluronan and CD44 is related to 
keratinocyte differentiation, cholesterol synthesis, and lamellar body formation, which are required 
for maintenance of normal stratum corneum structure and epidermal barrier function [16, 28].  In 
cultured cells, CD44 was constitutively phosphorylated at serine in the cytoplasmic tail [31-33].  In 
addition, hyaluronan-CD44 interaction with a small GTPase (Rac1)-dependent protein kinase N-γ 
(PKNγ) kinase activation promotes phosphorylation of phospholipase C (PLC) γ1 phosphorylation 
and cortactin, leading to the onset of PLC γ1-mediated IP3 production/Ca2+ signaling and 
cortactin-mediated cytoskeleton function required for keratinocyte function (e.g. cell-cell adhesion 
and differentiation) [28].  In this way, various signaling pathways were promoted by the 
hyaluronan-CD44 interaction.  In our study, CD44 mRNA expression and CD44-phosphorylated 
protein levels with HA4 treatment were increased that of the control (Fig. 6 and 7).  Altogether, 
HA4 enhanced keratinocyte differentiation and increased CD44-phosphorylated protein levels.  
However, CD44 mRNA expression and CD44-phosphorylated protein level have a time lag.  
Therefore, we thought that these two have not directly-involved.  The CD44 mRNA expression was 
increased by HA4 may involve in secondary action.  From these results, it was suggested that HA4 
enhanced keratinocyte differentiation through phosphorylation of CD44.  However, we don’t 
examine other factors which increases and decreases by epidermal differentiation through the 
phosphorylation of the CD44.  Accordingly, it is necessary to clarify the detailed mechanism of 
epidermal differentiation by HA4.  Our group previously reported that HA4 improved skin 
functional recovery after UVA irradiation [17].  That epidermal differentiation was enhanced by 
HA4 may be one of the factors for skin functional recovery after UVA irradiation.   
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Figure 1  Effect of HA and HA4 treatment on the cell viability of NHEKs.  Cell viability was 
determined by the MTT assay.  NHEKs were treated for 24 h with 1 µg/mL HA and HA4.  Values 
are the mean ± S.D. of three experiments. 
 
Figure 2  Effect of HA and HA4 treatment for 3 days on each differentiation marker mRNA 
expression in NHEKs.  K5 (A), K10 (B), involucrin (C), profilaggrin (D), and TGase (E) mRNA 
expressions were determined by quantitative real-time PCR.  NHEKs were treated for 3 days with 1 
µg/mL HA and HA4.  Values were normalized to GAPDH housekeeping gene levels and compared 
with untreated controls.  Values are the mean ± S.D. of three experiments.  *p < 0.05, Tukey’s 
post-hoc multiple comparison test. 
 
Figure 3  Effect of HA and HA4 treatment for 9 days on each differentiation marker mRNA 
expression in NHEKs.  K5 (A), K10 (B), involucrin (C), profilaggrin (D), and TGase (E) mRNA 
expressions were determined by quantitative real-time PCR.  NHEKs were treated for 9 days with 1 
µg/mL HA and HA4.  Values were normalized to GAPDH housekeeping gene levels and compared 
with untreated controls.  Values are the mean ± S.D. of three experiments.  *p < 0.05, **p < 0.01, 
Tukey’s post-hoc multiple comparison test. 
 
Figure 4  Effect of HA and HA4 treatment for 3 days on each differentiation marker protein 
evaluation in NHEKs.  K10 (A), involucrin (B), and filaggrin (C) proteins were determined by 
western blotting.  NHEKs were treated for 3 days with 1 µg/mL HA and HA4.  Values were 
normalized to β-actin housekeeping protein levels and compared with untreated controls.  Values 
are the mean ± S.D. of three experiments.  N.D., not determined.  *p < 0.05, Tukey’s post-hoc 
multiple comparison test. 
 
Figure 5  Effect of HA and HA4 treatment for 9 days on each differentiation markers protein 
evaluation in NHEKs.  K10 (A), involucrin (B) and filaggrin (C) protein were determined by 
western blotting.  NHEKs were treated for 9 days with 1 µg/mL HA and HA4.  Values were 
normalized to the β-actin housekeeping protein levels and compared with untreated control.  Values 
are the mean ± S.D. of three experiments.  *p < 0.05, Tukey’s post-hoc multiple comparison 
test. 
 
Figure 6  Effect of HA and HA4 on CD44 mRNA expression in NHEKs.  CD44 mRNA 
expression was determined by quantitative real-time PCR.  NHEKs were treated for 4 h, 8 h, 24 h, 
15 
and 216 h (9 days) with 1 µg/mL HA and HA4.  Values were normalized to GAPDH housekeeping 
gene levels and compared with untreated controls.  Values are the mean ± S.D. of three experiments.  
**p < 0.01, Tukey’s post-hoc multiple comparison test. 
 
Figure 7  Effect of HA and HA4 on CD44-phosphorylated protein evaluation in NHEKs.  
CD44-phosphorylated protein was determined by western blotting.  NHEKs were treated for 8 h 
(A) and 24 h (B) with 1 µg/mL HA and HA4.  Values were normalized to β-actin housekeeping 
protein levels and compared with untreated controls.  Values are the mean ± S.D. of three 
experiments.  **p < 0.01, Tukey’s post-hoc multiple comparison test. 
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Table I  Primer sequences 
Primer Sequence 
GAPDH Forward 5’-GAAGGTGAAGGTCGGAGT-3’ 
Reverse 5’-GAAGATGGTGATGGGATTTC-3’ 
Keratin 5 Forward 5’-GAGCTGAGAAACATGCAGGA-3’ 
Reverse 5’-TCTCAGCAGTGGTACGCTTG-3’ 
Keratin 10 Forward 5’-CCATCGATGACCTTAAAAATCAG-3’ 
Reverse 5’-GCAGAGCTACCTCATTCTCATACTT-3’ 
Involucrin Forward 5’-TGCCTGAGCAAGAATGTGAG-3’ 
Reverse 5’-TTCCTCATGCTGTTCCCAGT-3’ 
Profilaggrin Forward 5’-CCATCATGGATCTGCGTGG-3’ 
Reverse 5’-CACGAGAGGAAGTCTCTGCGT-3’ 
Transglutaminase Forward 5’-TCTTCAAGAACCCCCTTCCC-3’ 
Reverse 5’-TCTGTAACCCAGAGCCTTCGA-3’ 
CD44 Forward 5’-GACACCATGGACAAGTTTTGG-3’ 
Reverse 5’-CGGCAGGTTATATTCAAATCG-3’ 
 
 
 
